| MYC Deregulation in Primary Human Cancers M Kalkat, J De Melo, KA Hickman, C Lourenco, C Redel, D Resetca, ... Genes 8 (6), 151, 2017 | 359 | 2017 |
| MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis M Kalkat, D Resetca, C Lourenco, PK Chan, Y Wei, YJ Shiah, N Vitkin, ... Molecular cell 72 (5), 836-848. e7, 2018 | 174 | 2018 |
| BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors D Dingar, M Kalkat, PK Chan, T Srikumar, SD Bailey, WB Tu, E Coyaud, ... Journal of proteomics 118, 95-111, 2015 | 145 | 2015 |
| Immediate Utility of Two Approved Agents to Target Both the Metabolic Mevalonate Pathway and Its Restorative Feedback Loop A Pandyra, PJ Mullen, M Kalkat, R Yu, JT Pong, Z Li, S Trudel, KS Lang, ... Cancer research 74 (17), 4772-4782, 2014 | 80 | 2014 |
| Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell death AA Pandyra, PJ Mullen, CA Goard, E Ericson, P Sharma, M Kalkat, R Yu, ... Oncotarget 6 (29), 26909, 2015 | 69 | 2015 |
| Placental autophagy regulation by the BOK-MCL1 rheostat M Kalkat, J Garcia, J Ebrahimi, M Melland-Smith, T Todros, M Post, ... Autophagy 9 (12), 2140-2153, 2013 | 62 | 2013 |
| MYC dephosphorylation by the PP1/PNUTS phosphatase complex regulates chromatin binding and protein stability D Dingar, WB Tu, D Resetca, C Lourenco, A Tamachi, J De Melo, ... Nature communications 9 (1), 3502, 2018 | 51 | 2018 |
| DNA methylation dynamics and dysregulation delineated by high-throughput profiling in the mouse W Zhou, T Hinoue, B Barnes, O Mitchell, W Iqbal, SM Lee, KK Foy, ... Cell Genomics 2 (7), 100144, 2022 | 44 | 2022 |
| DNA methylation dynamics and dysregulation delineated by high-throughput profiling in the mouse W Zhou, T Hinoue, B Barnes, O Mitchell, W Iqbal, SM Lee, KK Foy, ... Cell genomics 2 (7), 2022 | 44 | 2022 |
| MYC phosphorylation at novel regulatory regions suppresses transforming activity AR Wasylishen, M Chan-Seng-Yue, C Bros, D Dingar, WB Tu, M Kalkat, ... Cancer research 73 (21), 6504-6515, 2013 | 43 | 2013 |
| Inhibiting MYC binding to the E-box DNA motif by ME47 decreases tumour xenograft growth LC Lustig, D Dingar, WB Tu, C Lourenco, M Kalkat, I Inamoto, R Ponzielli, ... Oncogene 36 (49), 6830-6837, 2017 | 35 | 2017 |
| Modelling the MYC-driven normal-to-tumour switch in breast cancer C Lourenco, M Kalkat, KE Houlahan, J De Melo, J Longo, SJ Done, ... Disease models & mechanisms 12 (7), dmm038083, 2019 | 22 | 2019 |
| Identification of c-MYC SUMOylation by mass spectrometry M Kalkat, PK Chan, AR Wasylishen, T Srikumar, SS Kim, R Ponzielli, ... PloS one 9 (12), e115337, 2014 | 22 | 2014 |
| MYC activity is negatively regulated by a C-terminal lysine cluster AR Wasylishen, M Kalkat, SS Kim, A Pandyra, PK Chan, S Oliveri, ... Oncogene 33 (8), 1066-1072, 2014 | 19 | 2014 |
| Targeting p130Cas-and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition AM Waters, TO Khatib, B Papke, CM Goodwin, GA Hobbs, JN Diehl, ... Cell Reports 35 (13), 109291, 2021 | 18 | 2021 |
| More than MAX: discovering the Myc interactome M Kalkat, AR Wasylishen, SS Kim, L Penn Cell Cycle 10 (3), 374-375, 2011 | 12 | 2011 |
| Data in Brief PK Chan, T Srikumar, D Dingar, M Kalkat, LZ Penn, B Raught | 10* | |
| Modeling the MYC-driven normal-to-tumour switch in breast cancer C Lourenco, M Kalkat, KE Houlahan, JD Melo, J Longo, SJ Done, ... bioRxiv, 380931, 2018 | 1 | 2018 |
| Abstract B04: In vivo BioID identifies novel Myc interacting partners D Dingar, M Kalkat, PK Chan, SD Bailey, T Srikumar, WB Tu, E Coyaud, ... Molecular Cancer Therapeutics 13 (10_Supplement), B04-B04, 2015 | 1 | 2015 |
| Regulation and Function of the MYC Oncogene M Kalkat, LZ Penn eLS, 0 | 1* | |
